These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1862730)

  • 21. Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine.
    Schweizer E; Rickels K; Weiss S; Zavodnick S
    Arch Gen Psychiatry; 1993 Jan; 50(1):51-60. PubMed ID: 8422222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Controlled trial of alprazolam supplementation during imipramine treatment of panic disorder.
    Woods SW; Nagy LM; Koleszar AS; Krystal JH; Heninger GR; Charney DS
    J Clin Psychopharmacol; 1992 Feb; 12(1):32-8. PubMed ID: 1552038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronology of panic and avoidance, age of onset in panic disorder, and prediction of treatment response. A report from the Cross-National Collaborative Panic Study.
    Buller R; Maier W; Goldenberg IM; Lavori PW; Benkert O
    Eur Arch Psychiatry Clin Neurosci; 1991; 240(3):163-8. PubMed ID: 1827602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Avoidance behaviour: a predictor of the efficacy of pharmacotherapy in panic disorder?
    Maier W; Roth SM; Argyle N; Buller R; Lavori P; Brandon S; Benkert O
    Eur Arch Psychiatry Clin Neurosci; 1991; 241(3):151-8. PubMed ID: 1790160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double-blind comparison of alprazolam and adinazolam for panic and phobic disorders.
    Pyke RE; Greenberg HS
    J Clin Psychopharmacol; 1989 Feb; 9(1):15-21. PubMed ID: 2651489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind, placebo-controlled study of a once-a-day, sustained-release preparation of alprazolam for the treatment of panic disorder.
    Schweizer E; Patterson W; Rickels K; Rosenthal M
    Am J Psychiatry; 1993 Aug; 150(8):1210-5. PubMed ID: 8328566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind comparison of alprazolam vs. imipramine and placebo in the treatment of major depressive disorder.
    Feighner JP; Meredith CH; Frost NR; Chammas S; Hendrickson G
    Acta Psychiatr Scand; 1983 Oct; 68(4):223-33. PubMed ID: 6138925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alprazolam, diazepam, imipramine, and placebo in outpatients with major depression.
    Rickels K; Chung HR; Csanalosi IB; Hurowitz AM; London J; Wiseman K; Kaplan M; Amsterdam JD
    Arch Gen Psychiatry; 1987 Oct; 44(10):862-6. PubMed ID: 3310952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment.
    Ballenger JC; Burrows GD; DuPont RL; Lesser IM; Noyes R; Pecknold JC; Rifkin A; Swinson RP
    Arch Gen Psychiatry; 1988 May; 45(5):413-22. PubMed ID: 3282478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of panic disorder in older adults: a pilot study comparison of alprazolam, imipramine, and placebo.
    Sheikh JI; Swales PJ
    Int J Psychiatry Med; 1999; 29(1):107-17. PubMed ID: 10376237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of alprazolam and imipramine in generalized anxiety disorder: somatic versus psychic symptoms.
    Hoehn-Saric R; McLeod DR; Zimmerli WD
    J Clin Psychiatry; 1988 Aug; 49(8):293-301. PubMed ID: 3045099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
    Lydiard RB; Ballenger JC; Rickels K
    J Clin Psychiatry; 1997; 58 Suppl 11():11-8. PubMed ID: 9363043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patients with panic disorder unaccompanied by depression improve with alprazolam and imipramine treatment.
    Deltito JA; Argyle N; Klerman GL
    J Clin Psychiatry; 1991 Mar; 52(3):121-7. PubMed ID: 2005075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder.
    Tesar GE; Rosenbaum JF; Pollack MH; Otto MW; Sachs GS; Herman JB; Cohen LS; Spier SA
    J Clin Psychiatry; 1991 Feb; 52(2):69-76. PubMed ID: 1993639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response of panic disorder to fixed doses of alprazolam or imipramine.
    Uhlenhuth EH; Matuzas W; Glass RM; Easton C
    J Affect Disord; 1989; 17(3):261-70. PubMed ID: 2529295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma alprazolam concentrations. Relation to efficacy and side effects in the treatment of panic disorder.
    Greenblatt DJ; Harmatz JS; Shader RI
    Arch Gen Psychiatry; 1993 Sep; 50(9):715-22. PubMed ID: 8357297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychopharmacological treatment of panic disorder and related states: a placebo controlled study of alprazolam.
    Swinson RP; Pecknold JC; Kuch K
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):105-13. PubMed ID: 3628823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergence of depressive symptoms in patients receiving alprazolam for panic disorder.
    Lydiard RB; Laraia MT; Ballenger JC; Howell EF
    Am J Psychiatry; 1987 May; 144(5):664-5. PubMed ID: 3578580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benzodiazepine treatment of panic disorder: a comparison of alprazolam and lorazepam.
    Charney DS; Woods SW
    J Clin Psychiatry; 1989 Nov; 50(11):418-23. PubMed ID: 2808308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo.
    Pollack MH; Otto MW; Sachs GS; Leon A; Shear MK; Deltito JA; Keller MB; Rosenbaum JF
    J Affect Disord; 1994 Apr; 30(4):273-81. PubMed ID: 8014326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.